Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, ...

The life-saving impact of global vaccine stockpiles to address outbreaks of vaccine-preventable diseases has been ...

Physicians who champion immunization sustain herd immunity, reducing the incidence of severe diseases, hospitalizations, and ...